News & Updates

Show Multimedia Only

Zenagamtide for T2D nabs phase II win

15 Aug 2026

In the treatment of patients with type 2 diabetes (T2D), the investigational zenagamtide helps improve glucose control, while having a safety and tolerability profile consistent with other GLP-1 and amylin receptor agonists, according to a dose-ranging phase II study.

Zenagamtide for T2D nabs phase II win

15 Aug 2026

การศึกษา STEP UP: เซมากลูไทด์ 7.2 มก. ให้ผลลดน้ำหนักเฉลี่ยประมาณ 21% ในผู้ใหญ่ที่มีโรคอ้วน

15 Aug 2026

การศึกษา STEP UP ที่ตีพิมพ์ในวารสาร The LANCET Diabetes & Endocrinology แสดงให้เห็นว่า ยาเซมากลูไทด์ ขนาด 7.2 มก. ซึ่งเป็นยาในกลุ่ม glucagon-like peptide-1 receptor agonist (GLP-1 RA) สามารถลดน้ำหนักตัวเฉลี่ยได้ประมาณ 21%*^,† จากค่าเริ่มต้น ณ สัปดาห์ที่ 72 ในผู้ใหญ่ที่มีโรคอ้วน¹ นับเป็นข้อมูลสำคัญที่สะท้อนประสิทธิภาพของการใช้ยาเซมากลูไทด์ในขนาดที่สูงขึ้นเพื่อเพิ่มผลลัพธ์ด้านการควบคุมน้ำหนัก

การศึกษา STEP UP: เซมากลูไทด์ 7.2 มก. ให้ผลลดน้ำหนักเฉลี่ยประมาณ 21% ในผู้ใหญ่ที่มีโรคอ้วน

15 Aug 2026

Comorbidities prevalent in patients with RA

14 Aug 2026 by

Patients with rheumatoid arthritis (RA) also suffer several comorbidities, the most common being circulatory and metabolic disorders, according to a Bangladesh study.

Comorbidities prevalent in patients with RA

14 Aug 2026

Semaglutide may extend benefits in COVID-19

14 Aug 2026 by

In a prespecified secondary analysis of the phase III FLOW trial, semaglutide reduces the risk of serious infections and COVID-19 events in individuals with type 2 diabetes (T2D) and chronic kidney disease (CKD).

Semaglutide may extend benefits in COVID-19

14 Aug 2026

Obesity tied to higher disease activity in children with JIA

13 Aug 2026

In children newly diagnosed with juvenile idiopathic arthritis (JIA), obesity is associated with increased disease activity and limited access to healthy food in chain grocery stores, suggests a Canada study.

Obesity tied to higher disease activity in children with JIA

13 Aug 2026

Electronic alerts improve CKD screening in patients with T2D

11 Aug 2026 by

An electronic health record (EHR)-integrated, alert-based computerized decision support (CDS) tool contributes to increased urine albumin-to-creatinine ratio (UACR) testing and early detection of elevated albuminuria among adults with type 2 diabetes (T2D), as shown in the CKD-DETECT trial.

Electronic alerts improve CKD screening in patients with T2D

11 Aug 2026

Mat Pilates, belly dance benefit women with breast cancer

08 Aug 2026

In women receiving hormone therapy for breast cancer, both mat Pilates and belly dance can help improve cardiorespiratory fitness and body composition, as shown in a study.

Mat Pilates, belly dance benefit women with breast cancer

08 Aug 2026

Bariatric surgery in teens with obesity reduces BMI, cardiometabolic risk factors

06 Aug 2026 by

Adolescents with obesity who underwent bariatric surgery (BS) show substantial and sustained improvements in BMI and cardiometabolic health, according to a study.

Bariatric surgery in teens with obesity reduces BMI, cardiometabolic risk factors

06 Aug 2026

Sleeve gastrectomy bests incretin-based therapies for obesity, type 2 diabetes

05 Aug 2026

In the real-world treatment of patients with obesity and type 2 diabetes, the probability of achieving combined weight and glycaemic targets is higher with sleeve gastrectomy than with either tirzepatide or semaglutide, according to a retrospective cohort study.

Sleeve gastrectomy bests incretin-based therapies for obesity, type 2 diabetes

05 Aug 2026

Low FT levels linked to frailty in men with advanced CLD

03 Aug 2026

Low levels of free testosterone (FT) appear to contribute to frailty in male patients with advanced chronic liver disease (CLD), according to a study.

Low FT levels linked to frailty in men with advanced CLD

03 Aug 2026

News & Updates

Showing Endocrinology articles

Showing

Specialty:

Zenagamtide for T2D nabs phase II win

Zenagamtide for T2D nabs phase II win

การศึกษา STEP UP: เซมากลูไทด์ 7.2 มก. ให้ผลลดน้ำหนักเฉลี่ยประมาณ 21% ในผู้ใหญ่ที่มีโรคอ้วน

การศึกษา STEP UP: เซมากลูไทด์ 7.2 มก. ให้ผลลดน้ำหนักเฉลี่ยประมาณ 21% ในผู้ใหญ่ที่มีโรคอ้วน

Comorbidities prevalent in patients with RA

Comorbidities prevalent in patients with RA

Semaglutide may extend benefits in COVID-19

Semaglutide may extend benefits in COVID-19

Obesity tied to higher disease activity in children with JIA

Obesity tied to higher disease activity in children with JIA

Electronic alerts improve CKD screening in patients with T2D

Electronic alerts improve CKD screening in patients with T2D

Mat Pilates, belly dance benefit women with breast cancer

Mat Pilates, belly dance benefit women with breast cancer

Bariatric surgery in teens with obesity reduces BMI, cardiometabolic risk factors

Bariatric surgery in teens with obesity reduces BMI, cardiometabolic risk factors

Sleeve gastrectomy bests incretin-based therapies for obesity, type 2 diabetes

Sleeve gastrectomy bests incretin-based therapies for obesity, type 2 diabetes

Low FT levels linked to frailty in men with advanced CLD

Low FT levels linked to frailty in men with advanced CLD